In this study, we discovered that FAF1 was significantly higher in tumoral tissues compared to non-tumoral tissues in NSCLC, and that it was significantly associated with poor prognosis, particularly in adenocarcinoma. This evidence concerns the gene FAF1 and adenocarcinoma.